Article

AAOS: Reduced Surgery Rates Document RA Treatment Success

Although joint and spine surgery rates are increasing, progressively fewer are being performed on patients with rheumatoid arthritis, according to studies from two different large registries.

Orthopedic surgeons are giving very public credit to rheumatology this week at their annual meeting. Although rates of both knee and cervical spine surgery have increased dramatically in the past few decade, the prevalences of total knee replacement (TKR) and cervical spine fusion among patients with rheumatoid arthritis (RA) have declined during the same period, according to two studies presented at the American Academy of Orthopaedic Surgeons meeting in Chicago. The authors of both studies credit dramatic improvements in drug treatments for RA.

Data in the Finnish Arthroplasty Register from 1980 through 2010 show a 20-fold increase in the overall incidence of TKRs, reported Eerik T. Skytta MD and coworkers from the COXA Hospital for Joint Replacement in Tampere, Finland. But the annual incidence of TKRs among RA patients has been gradually decreasing, most noticeably among patients over the age of 60 since 2005. (A separate analysis has shown a steady increase in patients with osteoarthritis over the three decades before 2011.)

To the authors' knowledge, this is the first time a decline in TKRs among RA patients has been demonstrated on a population level. It is due at least in part, they say to "early and aggressive approach to treatment and the availability of new effective treatments."

Researchers from Johns Hopkins Medicine report a similar trend in utilization of cervical spine fusions over a similar period, observed in data from the US National Inpatient Sample. Between 1992 and 2008, there was a 6.8% increase per year in cervical fusions among patients without RA, while those among patients with a diagnosis of RA declined by 1.6% per year. Johns Hopkins spine surgeon Khaled Kebaish MD and his coworkers credit the same developments: early, aggressive treatment and improved medical therapies.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.